Jane Wright-Mitchell
CIK: 0001614568
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VERA
Vera Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Wright-Mitchell Jane
Wright-Mitchell Jane (SEC CIK 0001614568) files insider reports with the SEC as Chief Legal Officer of Vera Therapeutics, Inc. (VERA).
Signal8 holds 2 ownership filings by Wright-Mitchell Jane (1 Form 3, 1 Form 4), filed on Mar 25, 2026. Those filings report 1 transaction, the latest on Mar 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wright-Mitchell Jane's filings is in BRISBANE, CA.
Recent filings by Wright-Mitchell Jane
- Mar 23, 2026: Grant or award of VERA shares (Form 4, code A).
Other insiders filing for Vera Therapeutics, Inc. (VERA)
- Fordyce Marshall, PRESIDENT AND CEO
- Young Joseph R, SVP, FINANCE, CHIEF ACCT OFFCR
- Boman Nancy Lee, Chief Regulatory Officer
- Morrison Scott W, Director
- Cheng Andrew, Director
- SEIDENBERG BETH C, Director